CAM
DGX icon

Cresset Asset Management’s Quest Diagnostics DGX Stock Holding History

Cresset Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$771K Buy
3,637
+4
+0.1% +$785 ﹤0.01% 1012
2026
Q1 		$712K Buy
3,633
+71
+2% +$13.8K ﹤0.01% 912
2025
Q4 		$618K Sell
3,562
-335
-9% -$61K ﹤0.01% 980
2025
Q3 		$743K Buy
3,897
+444
+13% +$78.8K ﹤0.01% 864
2025
Q2 		$620K Sell
3,453
-374
-10% -$65K ﹤0.01% 840
2025
Q1 		$648K Sell
3,827
-471
-11% -$77.4K ﹤0.01% 949
2024
Q4 		$648K Sell
4,298
-8,496
-66% -$1.32M ﹤0.01% 973
2024
Q3 		$1.99M Sell
12,794
-674
-5% -$101K 0.01% 816
2024
Q2 		$1.84M Buy
13,468
+6,793
+102% +$930K 0.01% 755
2024
Q1 		$889K Buy
6,675
+169
+3% +$21.9K ﹤0.01% 1041
2023
Q4 		$897K Sell
6,506
-1,092
-14% -$144K 0.01% 940
2023
Q3 		$926K Sell
7,598
-1,469
-16% -$196K ﹤0.01% 890
2023
Q2 		$1.27M Buy
9,067
+7,076
+355% +$975K ﹤0.01% 828
2023
Q1 		$282K Sell
1,991
-92
-4% -$13.2K 0.01% 648
2022
Q4 		$275K Sell
2,083
-131
-6% -$18.8K ﹤0.01% 550
2022
Q3 		$271K Sell
2,214
-740
-25% -$97.5K ﹤0.01% 700
2022
Q2 		$393K Buy
2,954
+17
+0.6% +$2.32K ﹤0.01% 629
2022
Q1 		$402K Sell
2,937
-519
-15% -$72.3K ﹤0.01% 676
2021
Q4 		$598K Buy
3,456
+1,288
+59% +$196K 0.01% 638
2021
Q3 		$314K Buy
2,168
+201
+10% +$29.4K ﹤0.01% 824
2021
Q2 		$259K Buy
1,967
+380
+24% +$49.8K ﹤0.01% 841
2021
Q1 		$204K Buy
+1,587
New +$196K ﹤0.01% 858
2019
Q2 		– Sell
-800
Closed -$72K – 776
2019
Q1 		$72K Buy
800
+679
+561% +$58.8K ﹤0.01% 663
2018
Q4 		$10K Buy
+121
New +$11.3K ﹤0.01% 855

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Cresset Asset Management's DGX Position: Q2 2026 in Review

Cresset Asset Management increased its Quest Diagnostics (DGX) stake by 0.11% in Q2 2026, buying an estimated $785 and bringing the position to 3,637 shares worth $771K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Cresset Asset Management first reported a position in DGX in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.99M in Q3 2024. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Cresset Asset Management held 3,637 shares of Quest Diagnostics worth $771K as of Q2 2026.
  • Cresset Asset Management bought 4 Quest Diagnostics shares in Q2 2026, an estimated $785.
  • Quest Diagnostics made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1012 holding.
  • Cresset Asset Management first reported a position in Quest Diagnostics in Q4 2018 and has held it in 24 quarters since.
  • Cresset Asset Management's Quest Diagnostics position peaked at $1.99M in Q3 2024.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.